Joel Isaacson & Co’s Labcorp LH Stock Holding History

Joel Isaacson & Co’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-30	Closed	-$3K	–	368
2016 Q4	$3K	Hold	30	–	–	﹤0.01%	589
2016 Q3	$4K	Hold	30	–	–	﹤0.01%	637
2016 Q2	$3K	Hold	30	–	–	﹤0.01%	648
2016 Q1	$3K	Hold	30	–	–	﹤0.01%	699
2015 Q4	$3K	Hold	30	–	–	﹤0.01%	661
2015 Q3	$3K	Hold	30	–	–	﹤0.01%	662
2015 Q2	$3K	Hold	30	–	–	﹤0.01%	687
2015 Q1	$3K	Buy	30 +24	+400%	+$2.47K	﹤0.01%	638
2014 Q4	$1K	Buy	+6	New	+$530	﹤0.01%	613

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Joel Isaacson & Co's LH Position: Q1 2017 in Review

Joel Isaacson & Co sold out of Labcorp (LH) in Q1 2017, closing a stake of 30 shares — an estimated $3K sold.

Joel Isaacson & Co first reported a position in LH in Q4 2014 and held it in 9 quarters. The position peaked at $4K in Q3 2016. 693 funds tracked by Wall St. Rank hold LH as of Q1 2017.

Joel Isaacson & Co reported no remaining Labcorp position as of Q1 2017 after selling out during the quarter.
Joel Isaacson & Co sold 30 Labcorp shares in Q1 2017, an estimated $3K.
Joel Isaacson & Co first reported a position in Labcorp in Q4 2014 and held it in 9 quarters.
Joel Isaacson & Co's Labcorp position peaked at $4K in Q3 2016.
693 funds tracked by Wall St. Rank held Labcorp as of Q1 2017.

Based on Joel Isaacson & Co's 13F filing for Q1 2017, filed 5 May 2017.